M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT04803682
This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.
Looking for future studies?
Notify Me13 year–18 year
All sexes
Interventional
Early Phase 1
Houston, Texas, 77030, United States
PRIMARY OBJECTIVES:
I. To evaluate the feasibility of training selected eleventh grade high school student volunteers to provide an intervention involving mentoring combined with social support activities.
II. To increase ninth grade high school student well-being, which would ultimately influence tobacco related knowledge and resistance skills regarding tobacco uptake among ninth grade high school program participants.
EXPLORATORY OBJECTIVES:
I. Mentor ability, confidence, and intention (ACI) to address tobacco use and dependence and providing anti-tobacco advice to mentees.
II. To determine the scores on mentoring competencies. III. To determine the influences of social support and self-esteem by mentors. IV. To determine the quality and satisfaction with the relationships among mentors and mentees.
V. To determine level of knowledge about nicotine and tobacco products among mentees.
VI. To determine susceptibility to tobacco use among non-smokers. VII. To determine progression through stages of change among smokers.
OUTLINE:
Participants complete online ASPIRE course over 3.5-4 hours.
HIGH SCHOOL MENTORS: Eleventh grade high school students receive mentor training over 4-5 hours on how to mentor ninth grade students.
ALL STUDENTS: Mentors and mentees are paired up so that eleventh grade high school students mentor the ninth grade high school students over 30 minutes for 7 sessions about the different types of tobacco products (such as cigarettes, cigars, hookah, and so on) and the dangers of these products.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participate in ASPIRE and mentorship program
Other names: PREVENTATIVE, Prevention, Prevention Measures, prophylaxis, PRYLX
Ancillary studies (pre and post questionnaire)
Time frame: 3 years
At least 40 mentors and 100 mentees.
Time frame: 3 years
At least 80% completion rates.
Time frame: 3 years
At least 5 of 7 sessions of mentor/mentee interactions
Time frame: 3 years
Training program for mentors and overall program satisfaction. Seventeen-item rating scale (1 = not skilled at all to 7 = extremely skilled) about facets of mentoring.
Time frame: 3 years
Assessed by comparing pre and post intervention scores. Three-item rating scale (0 = no ability/confidence/intention to 4 = high ability, confidence, and intention) Nineteen-item scale measuring quality of mentor to mentee relationship. Four point Likert scale (1 = not true at all to 4 = very true) Twenty-five item scale. Multiple choice questions to measure tobacco and nicotine product knowledge developed by ASPIRE study team
M.D. Anderson Cancer Center
Other
ASPIRE+ Mentoring Moon Shot Youth Lung Prevention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05011799
Genital Diseases, Genital Diseases, Male
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02168738
Healthy Subject
Pierre-Bénite, France
View Trial DetailsNCT04614155
Healthy Subject
Houston, Texas, United States
View Trial DetailsNCT06920719
Healthy Subject
Seoul, South Korea
View Trial Details